Market Analysis
Drug-treated diabetic retinopathy population to quadruple by 2012
Published in Obesity and Diabetes Week, May 3rd, 2004
"The availability of effective surgical treatments coupled with the near total lack of effective pharmacotherapy for diabetic retinopathy has kept drug-treated rates - and thus pharmaceutical sales for this disease - exceedingly low," said Kat Neumeyer, analyst at Decision Resources. "However, the launch of novel drug therapies will prompt dramatic increases in the drug- treated population, which will nearly quadruple in the major pharmaceutical markets (United States, France, Germany, Spain, Italy, Japan, and the United Kingdom)."
According...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
SREBP-1c expression in liver of diabetic mice is insulin independent - Obesity Genomics and Genetics
Genetic polymorphisms in PPAR-delta associated with obesity - Obesity and Diabetes
Overweight children at high risk for developing hyperinsulinemia - Type 2 Diabetes
Reduced lipid oxidation in muscle in type 2 diabetes may be genetic - Type 2 Diabetes Pathogenesis
Glucose induces human apolipoprotein A-II gene transcription - Angiology
Antioxidants may mediate exercise-induced drop in platelet activity - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
